Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2016 / Nov / Tiny Testing
Oncology Technology and innovation Oncology Analytical science Point of care testing Precision medicine Clinical care Laboratory management Research and Innovations

Tiny Testing

A new device allows pathologists to look for cancer biomarkers in eight samples at once – affordably, accurately, and on a smartphone

By Michael Schubert 11/17/2016 1 min read

Share

In the hunt for better diagnostics, the game is always afoot. We want them fast, cheap, accurate and portable – attributes that aren’t always easy to combine into a single device. But now, a group of researchers think they may have cracked the code with a new “smartphone laboratory” (1) designed to detect the cancer biomarker interleukin-6 (IL-6).

A diagram of the smartphone laboratory in action. (Credit: Washington State University.)

Who? A Washington State University research group in the School of Mechanical and Materials Engineering. The project is led by Lei Li, an assistant professor with an interest in diagnostics and precision engineering. What? A portable, eight-channel spectrometer that works with an iPhone 5. By using 3D-printed accessories and a newly developed manufacturing process, the researchers were able to bring the cost of the device down to less than US$150. Why? Current smartphone spectrometers are single-channel, meaning that they can only analyze one sample at a time. That makes them slow if multiple samples are tested, or risks decreasing accuracy if users examine only one or a few samples. Running eight samples at once allows the WSU scientists’ device to not only work more efficiently, but also deliver results with up to 99 percent accuracy – as good as laboratory-based tests. This is especially useful for pathologists working in remote or resource-limited settings, where full laboratory setups may not be available. How? The spectrometer runs ELISA tests, using spectrometry to measure the change in color as antibodies in the assay react to IL-6 in the samples. IL-6 is a known biomarker for numerous cancers, including lung, liver, breast, prostate and epithelial – so its presence in a sample indicates a potential malignant tumor. What next? Li is working on a newer version of the device that can be adjusted to work with any model of smartphone. In the meantime, he and his colleagues are testing the existing device in real-world situations to see how it might perform in the field.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. LJ Wang et al., “A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics”, Biosens Bioelectron, 87, 686–692 (2016). PMID: 27631683.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.